New App Available For Teesside Lung Patients

Patients suffering from long-term lung conditions in Teesside are set to benefit from the arrival of a free new app.

Called ‘myCOPD’, the app has been created to support any patients suffering from Chronic Obstructive Pulmonary Disease (COPD).

COPD is the name for a group of chronic lung conditions that cause breathing difficulties, which can become gradually worse over time and limit normal activities.

The specialist app is currently the only app approved by the NHS on the new NHS App store and helps patients perfect their inhaler technique, get expert advice and complete rehabilitation from the comfort of their own home.

The app has been developed with clinicians and is offered to patients through GP practices, respiratory nurses within South Tees Hospitals NHS Foundation or as part of a pulmonary rehabilitation programme.

Dr Janet Walker, Chair of South Tees CCG, has urged any COPD patients to download the app, which has been developed by mymhealth.

She said: “I hope this will be a useful tool for some of the thousands of patients with COPD in Teesside.

“It’s simple and easy to use and can help patients to improve their symptoms, reduce breathlessness and improve quality of life and well-being.

“Many patients struggle with how to use their inhaler and often the drugs never reach the right place in the lungs to work effectively. The app has been shown to allow 90 per cent of patients to get more benefit from their inhalers.

“Like most respiratory conditions, there are times when COPD gets worse. The app should help patients spot the signs of a flare up and mean they are able to deal with it better.

“My patients want to be in more control of their condition, keep well and most importantly stay at home and avoid having to go into hospital. The app will help many achieve this.”

Find out more on the myCOPD app by visiting https://mymhealth.com/mycopd or emailing info@mymhealth.com.

Comments Off on New App Available For Teesside Lung Patients

Filed under News

Comments are closed.